Stock Rich List
#5979 on the rich list of 14,644 insiders

Jennifer Jarrett

Director, President and CEO at Damora Therapeutics; Chief Operating Officer at Arcus Biosciences; Director at Syndax Pharmaceuticals. Based in Waltham, Massachusetts.

$16.5M
in disclosed stock, +$713K (+4.52%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
5979th of 14,644
Companies held
3
Largest holding
DMRA, 75.4% of total
Latest SEC filing
Sep 25, 2026

What the $16.5M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Damora Therapeutics DMRA
Ordinary Shares
Directly512,500$24.30$12.5M75.4%Form 4, Sep 25, 2026
Arcus Biosciences RCUS
Common Stock
Directly224,024$15.78$3.5M21.4%Form 4, Jan 23, 2026
Syndax Pharmaceuticals SNDX
Common Stock
Directly
Reported jointly by 2 insiders; split evenly
57,000$9.13$520K3.2%Form 4, Feb 4, 2026

Share counts are the amounts Jennifer Jarrett reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Sep 25, 2026BoughtDMRA12,500$20.23$253KView
Dec 17, 2025SoldRCUS9,983$22.16$221KView
Dec 16, 2025SoldRCUS11,225$21.88$246KView
Nov 7, 2025SoldRCUS50,291$18.97$954KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
5976John Lycouris
Head of Energy Transition, Dorian LPG. Stamford, CT
$16.5M−$40K (−0.24%)
5977Rudolf A. Bless
Chief Accounting Officer, Bank of America. Charlotte, NC
$16.5M−$116K (−0.70%)
5978Richard V. McPhail
EVP & CFO, The Home Depot. Atlanta, GA
$16.5M−$47K (−0.28%)
5979Jennifer Jarrett
Director, President and CEO, Damora Therapeutics. Waltham, MA
$16.5M+$713K (+4.52%)
5980Blake Borgeson
Director, Recursion Pharmaceuticals. Salt Lake City, UT
$16.5M−$637K (−3.72%)
5981Jason Klurfeld
General Counsel, Evercore. New York, NY
$16.5M−$238K (−1.42%)
5982Glenn A. Eisenberg
Executive Vice President, Labcorp Holdings. Northridge, CA
$16.5M−$115K (−0.69%)

Other Damora Therapeutics insiders

All DMRA insiders

Questions

How much stock does Jennifer Jarrett own?

Jennifer Jarrett holds $16,509,259 in listed stock based on SEC filings and current prices, mostly Damora Therapeutics (DMRA). That ranks 5979th on the Stock Rich List.

Is this Jennifer Jarrett's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Jennifer Jarrett last buy or sell stock?

The most recent open-market trade on file is a purchase of 12,500 DMRA shares on Sep 25, 2026 at $20.23.